{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:47:29Z","timestamp":1793483249983,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Astellas Pharma, Inc."},{"name":"NIH","award":["P30-EY026877"],"award-info":[{"award-number":["P30-EY026877"]}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s40123-022-00583-y","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T18:02:55Z","timestamp":1668189775000},"page":"325-340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Dry Age-Related Macular Degeneration: Distribution of Visual Acuity and Progression Risk in a Large Registry"],"prefix":"10.1007","volume":"12","author":[{"given":"Theodore","family":"Leng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nimke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gallivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Fevrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Rozario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil M.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"issue":"1","key":"583_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuron.2012.06.018","volume":"75","author":"J Ambati","year":"2012","unstructured":"Ambati J, Fowler BJ. Mechanisms of age-related macular degeneration. Neuron. 2012;75(1):26\u201339. https:\/\/doi.org\/10.1016\/j.neuron.2012.06.018.","journal-title":"Neuron"},{"issue":"1","key":"583_CR2","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1016\/j.ophtha.2019.09.024","volume":"127","author":"CJ Flaxel","year":"2020","unstructured":"Flaxel CJ, Adelman RA, Bailey ST, et al. Age-related macular degeneration Preferred Practice Pattern\u00ae. Ophthalmology. 2020;127(1):P1\u2013P65.","journal-title":"Ophthalmology"},{"issue":"2","key":"583_CR3","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106\u201316.","journal-title":"Lancet Glob Health"},{"key":"583_CR4","unstructured":"National Institute of Health (NIH). National Eye Institute (NEI): Age-related macular degeneration (AMD) data and statistics. https:\/\/www.nei.nih.gov\/learn-about-eye-health\/outreach-campaigns-and-resources\/eye-health-data-and-statistics\/age-related-macular-degeneration-amd-data-and-statistics\/age-related-macular-degeneration-amd-tables Accessed 17 Dec 2021."},{"issue":"3","key":"583_CR5","first-page":"37","volume":"27","author":"MT Halpern","year":"2006","unstructured":"Halpern MT, Schmier JK, Covert D, Venkataraman K. Resource utilization and costs of age-related macular degeneration. Health Care Financ Rev. 2006;27(3):37\u201347.","journal-title":"Health Care Financ Rev"},{"issue":"4","key":"583_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ajo.2012.04.017","volume":"154","author":"JK Schmier","year":"2012","unstructured":"Schmier JK, Covert DW, Lau EC. Patterns and costs associated with progression of age-related macular degeneration. Am J Ophthalmol. 2012;154(4):675-81.e1. https:\/\/doi.org\/10.1016\/j.ajo.2012.04.017.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"583_CR7","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.ophtha.2017.11.036","volume":"125","author":"U Chakravarthy","year":"2018","unstructured":"Chakravarthy U, Bailey CC, Johnston RL, et al. Characterizing disease burden and progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology. 2018;125(6):842\u20139. https:\/\/doi.org\/10.1016\/j.ophtha.2017.11.036.","journal-title":"Ophthalmology"},{"issue":"12","key":"583_CR8","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.ophtha.2018.05.028","volume":"125","author":"TD Keenan","year":"2018","unstructured":"Keenan TD, Agr\u00f3n E, Domalpally A, et al. Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16. Ophthalmology. 2018;125(12):1913\u201328. https:\/\/doi.org\/10.1016\/j.ophtha.2018.05.028.","journal-title":"Ophthalmology"},{"issue":"1","key":"583_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ophtha.2005.08.012","volume":"113","author":"MC Leske","year":"2006","unstructured":"Leske MC, Wu SY, Hennis A, et al. Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies. Ophthalmology. 2006;113(1):29\u201335. https:\/\/doi.org\/10.1016\/j.ophtha.2005.08.012.","journal-title":"Ophthalmology"},{"key":"583_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/opth.S226425","volume":"14","author":"PJ Patel","year":"2020","unstructured":"Patel PJ, Ziemssen F, Ng E, et al. Burden of illness in geographic atrophy: a study of vision-related quality of life and health care resource use. Clin Ophthalmol. 2020;14:15\u201328. https:\/\/doi.org\/10.2147\/opth.S226425.","journal-title":"Clin Ophthalmol"},{"key":"583_CR11","first-page":"25","volume":"5","author":"JS Sunness","year":"1999","unstructured":"Sunness JS. The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration. Mol Vis. 1999;5:25.","journal-title":"Mol Vis"},{"issue":"9","key":"583_CR12","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/s0161-6420(99)90340-8","volume":"106","author":"JS Sunness","year":"1999","unstructured":"Sunness JS, Gonzalez-Baron J, Applegate CA, et al. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration. Ophthalmology. 1999;106(9):1768\u201379. https:\/\/doi.org\/10.1016\/s0161-6420(99)90340-8.","journal-title":"Ophthalmology"},{"issue":"2","key":"583_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ophtha.2006.09.016","volume":"114","author":"JS Sunness","year":"2007","unstructured":"Sunness JS, Margalit E, Srikumaran D, et al. The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials. Ophthalmology. 2007;114(2):271\u20137. https:\/\/doi.org\/10.1016\/j.ophtha.2006.09.016.","journal-title":"Ophthalmology"},{"issue":"2","key":"583_CR14","doi-asserted-by":"publisher","DOI":"10.2196\/medinform.4732","volume":"4","author":"M Mbagwu","year":"2016","unstructured":"Mbagwu M, French DD, Gill M, et al. Creation of an accurate algorithm to detect Snellen best documented visual acuity from ophthalmology electronic health record notes. JMIR Med Inform. 2016;4(2):e14. https:\/\/doi.org\/10.2196\/medinform.4732.","journal-title":"JMIR Med Inform"},{"key":"583_CR15","unstructured":"U.S. Centers for Medicare & Medicaid Services: NPPES NPI Registry. https:\/\/npiregistry.cms.hhs.gov\/ Accessed 12 May 2022."},{"issue":"19","key":"583_CR16","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1001\/jama.2013.4997","volume":"309","author":"Age-Related Eye Disease Study 2 Research Group","year":"2013","unstructured":"Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005\u201315. https:\/\/doi.org\/10.1001\/jama.2013.4997.","journal-title":"JAMA"},{"issue":"7","key":"583_CR17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1001\/jamaophthalmol.2013.4412","volume":"131","author":"EY Chew","year":"2013","unstructured":"Chew EY, SanGiovanni JP, Ferris FL, et al. Lutein\/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no 4. JAMA Ophthalmol. 2013;131(7):843\u201350. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.4412.","journal-title":"JAMA Ophthalmol"},{"issue":"35","key":"583_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3126\/kumj.v9i3.6298","volume":"9","author":"R Thapa","year":"2011","unstructured":"Thapa R, Paudyal G, Shrestha MK, Gurung R, Ruit S. Age-related macular degeneration in Nepal. Kathmandu Univ Med J (KUMJ). 2011;9(35):165\u20139. https:\/\/doi.org\/10.3126\/kumj.v9i3.6298.","journal-title":"Kathmandu Univ Med J (KUMJ)"},{"issue":"7","key":"583_CR19","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1136\/bjo.82.7.743","volume":"82","author":"JJ Wang","year":"1998","unstructured":"Wang JJ, Mitchell P, Smith W, Cumming RG. Bilateral involvement by age related maculopathy lesions in a population. Br J Ophthalmol. 1998;82(7):743\u20137. https:\/\/doi.org\/10.1136\/bjo.82.7.743.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"583_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.oret.2020.10.008","volume":"5","author":"CK Hwang","year":"2021","unstructured":"Hwang CK, Agr\u00f3n E, Domalpally A, et al. Progression of geographic atrophy with subsequent exudative neovascular disease in age-related macular degeneration: AREDS2 Report 24. Ophthalmol Retina. 2021;5(2):108\u201317. https:\/\/doi.org\/10.1016\/j.oret.2020.10.008.","journal-title":"Ophthalmol Retina"},{"issue":"7","key":"583_CR21","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.oret.2020.01.012","volume":"4","author":"U Chakravarthy","year":"2020","unstructured":"Chakravarthy U, Bailey CC, Scanlon PH, et al. Progression from early\/intermediate to advanced forms of age-related macular degeneration in a large UK cohort: rates and risk factors. Ophthalmol Retina. 2020;4(7):662\u201372. https:\/\/doi.org\/10.1016\/j.oret.2020.01.012.","journal-title":"Ophthalmol Retina"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-022-00583-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-022-00583-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-022-00583-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T17:15:50Z","timestamp":1673457350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-022-00583-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["583"],"URL":"https:\/\/doi.org\/10.1007\/s40123-022-00583-y","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]},"assertion":[{"value":"13 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}